Compare Monster Beverage Corp (MNST) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Monster Beverage Corp vs Nuwellis Inc — how do they compare? Monster Beverage Corp trades at $43.02 (market cap $84.53B), while Nuwellis Inc trades at $0.8 (market cap $2.50M). The key difference: Monster Beverage Corp is far larger — about 33812× Nuwellis Inc's market cap, and Monster Beverage Corp is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| MNST | NUWE | |
|---|---|---|
Market Cap | $84.53B | $2.50M |
Sector | Consumer Staples | Technology |
52-Week High | $49.97 | $164.50 |
52-Week Low | $31.41 | $0.73 |
Enterprise Value | $82.83B | -$1.21M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Monster Beverage (MNST) trades at $43.15, down 1.53% on the day, following a recent 2-for-1 stock split completed in August 2026. The stock exhibits a bullish technical signal from oscillators despite bearish moving averages, with key support at $42. Fundamentally, the company reported strong Q2 2026 earnings, beating estimates with $0.30 EPS, and shows robust revenue growth, with 2025 revenue reaching $8.29 billion and net income of $1.91 billion. Profitability remains high, with a net margin of 23.08% and ROE of 25.7%.
The outlook for MNST is positive, driven by consistent earnings beats, international expansion accounting for 46% of sales, and analyst consensus favoring a buy rating with a $51.10 price target. Key risks include elevated valuation multiples, such as a P/E of 39.95, and competitive pressures in the energy drink sector. Investors should weigh growth prospects against premium pricing.
NUWE trades at $0.7878, up 0.88% today, but remains in a bearish technical trend. The company shows strong gross margins of 69.69% and double-digit revenue growth, but faces significant profitability challenges with negative net income margins and ROE. Recent developments include a reverse stock split, new CEO appointment, and strategic partnerships expanding pediatric care footprint.
While NUWE demonstrates operational progress with revenue growth and margin improvement, persistent losses and negative cash flow present substantial risk. The mixed analyst sentiment and bearish technical indicators suggest cautious approach. Investment appeal hinges on successful execution of financial efficiency strategy and path to profitability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Monster Beverage Corp
Monster Beverage is a leader in the energy drink subsegment of the beverage industry. The Monster trademark anchors the portfolio, and notable offerings include Monster Energy and Monster Ultra. The firm has also started to incubate new trademarks for emerging enclaves of the energy space, like Reign in performance energy. It is primarily a brand owner, outsourcing most of its manufacturing processes to third-party copackers. It primarily uses the Coca-Cola bottling system for distribution after a strategic agreement in which Coke became Monster's largest shareholder (nearly 20%) and that also included the exchange of certain businesses between the two firms. Most of Monster's revenue is generated in the United States, though international geographies are increasing in the mix.
Read more on MNST →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
